K
Kyoko Komai
Researcher at Keio University
Publications - 14
Citations - 1180
Kyoko Komai is an academic researcher from Keio University. The author has contributed to research in topics: T cell & Immune tolerance. The author has an hindex of 10, co-authored 13 publications receiving 796 citations. Previous affiliations of Kyoko Komai include Japan Agency for Medical Research and Development.
Papers
More filters
Journal ArticleDOI
Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery
Minako Ito,Kyoko Komai,Setsuko Mise-Omata,Mana Iizuka-Koga,Yoshiko Noguchi,Taisuke Kondo,Ryota Sakai,Kazuhiko Matsuo,Takashi Nakayama,Osamu Yoshie,Hiroko Nakatsukasa,Shunsuke Chikuma,Takashi Shichita,Takashi Shichita,Akihiko Yoshimura +14 more
TL;DR: It is shown that there is massive accumulation of Treg cells in the mouse brain after ischaemic stroke, and this potentiates neurological recovery during the chronic phase of ischaemia brain injury.
Journal ArticleDOI
Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells.
Ikkou Kashiwagi,Rimpei Morita,Takashi Schichita,Kyoko Komai,Keita Saeki,Makoto Matsumoto,Kiyoshi Takeda,Masatoshi Nomura,Atsushi Hayashi,Takanori Kanai,Akihiko Yoshimura +10 more
TL;DR: A novel mechanism of TGF-β induction by Clostridia is revealed through a cooperation between TLR2-AP-1 and T GF-β-Smad signaling pathways.
Journal ArticleDOI
The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential.
Hiroyuki Mori,Ken Inoki,Kohsuke Masutani,Yu Wakabayashi,Kyoko Komai,Ryusuke Nakagawa,Kun-Liang Guan,Akihiko Yoshimura +7 more
TL;DR: It is found that diabetic db/db mice which lack the leptin receptor signaling can be used as a model of ESRD associated with DN and systemic administration of rapamycin markedly ameliorated pathological changes and renal dysfunctions, indicating that mTOR activation plays a pivotal role in the development of E SRD.
Journal ArticleDOI
MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1
Takashi Shichita,Minako Ito,Minako Ito,Rimpei Morita,Rimpei Morita,Kyoko Komai,Kyoko Komai,Yoshiko Noguchi,Yoshiko Noguchi,Hiroaki Ooboshi,Ryusuke Koshida,Satoru Takahashi,Tatsuhiko Kodama,Akihiko Yoshimura,Akihiko Yoshimura +14 more
TL;DR: It is demonstrated that common DAMPs, such as high-mobility-group box 1 (HMGB1), peroxiredoxins, and S100A8 and S 100A9, were internalized through the class A scavenger receptors MSR1 and MARCO in vitro, and cellular mechanisms contributing to DAMP clearance in resolution of the sterile inflammation triggered by tissue injury are uncovered.
Journal ArticleDOI
Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance
Takatoshi Chinen,Kyoko Komai,Go Muto,Rimpei Morita,Naoko Inoue,Hideyuki Yoshida,Takashi Sekiya,Ryoko Yoshida,Kazuhiko Nakamura,Ryoichi Takayanagi,Akihiko Yoshimura +10 more
TL;DR: It is proposed that SOCS1 and PGE2, potentially interacting together, act as an alternative intestinal tolerance mechanism distinct from IL-10 and Tregs, as an essential mediator of immune tolerance in the intestine.